Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
<h4>Background</h4>Expanding access to shorter regimens for tuberculosis (TB) prevention, such as once-weekly isoniazid and rifapentine taken for 3 months (3HP), is critical for reducing global TB burden among people living with HIV (PLHIV). Our coprimary hypotheses were that high levels...
Main Authors: | Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Lydia Akello, Lynn Kunihira Tinka, Jane Nakimuli, Joan Ritar Kasidi, Opira Bishop, Suzan Nakasendwa, Yeonsoo Baik, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick Pj Phillips, Anne Katahoire, Christopher A Berger, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-02-01
|
Series: | PLoS Medicine |
Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004356&type=printable |
Similar Items
-
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
by: Allan Musinguzi, et al.
Published: (2024-01-01) -
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
by: Fred C Semitala, et al.
Published: (2021-12-01) -
Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives
by: Fred C. Semitala, et al.
Published: (2021-06-01) -
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
by: A. Musinguzi, et al.
Published: (2024-02-01) -
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda
by: Jillian L. Kadota, et al.
Published: (2020-08-01)